Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
894 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05808920 | The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck(RESCUE) | recruiting | — | 400 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer | recruiting | Phase 3 | 550 | Jazz Pharmaceuticals |
| 15 |
| Feb 10, 2026 |
| clinicaltrials |
| NCT04895436 | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)(ReVenG) | recruiting | Phase 2 | 75 | AbbVieINDUSTRY | 11 | Feb 9, 2026 | clinicaltrials |
| NCT06534190 | CD8 PET Imaging in Metastatic Solid Tumours | recruiting | Phase 2 | 30 | University Medical Center GroningenOTHER | 3 | Feb 9, 2026 | clinicaltrials |
| NCT06748001 | Avapritinib Rollover Study | recruiting | Phase 4 | 60 | Blueprint Medicines CorporationINDUSTRY | 6 | Feb 9, 2026 | clinicaltrials |
| NCT07395037 | A Study of Ward Admissions for Haematuria(WASHOUT) | recruiting | — | 1,050 | British Urology Researchers in Surgical TrainingOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06127407 | Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen(CHONQUER) | recruiting | Phase 3 | 136 | Servier Bio-Innovation LLCINDUSTRY | 17 | Feb 6, 2026 | clinicaltrials |
| NCT07391215 | 5G-PEARL: Paxalisib in Malignant Brain Tumours(5G-PEARL) | recruiting | Phase 1 / Phase 2 | 64 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05111964 | HIFU Ablation of Soft Tissue Sarcoma(SarcAblate) | recruiting | N/A | 10 | Oxford University Hospitals NHS TrustOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05810467 | The Active Surveillance Study(AS) | recruiting | — | 200 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06636526 | The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). | recruiting | — | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06651658 | Oxford Pleural Embolisation Trial(OxPET) | recruiting | N/A | 106 | Oxford University Hospitals NHS TrustOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07375420 | Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?(OPTIMUS) | recruiting | N/A | 50 | University of SurreyOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07243834 | Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise(ADHERE) | recruiting | N/A | 160 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07365072 | The PRIMROSE Trial(PRIMROSE) | recruiting | N/A | 100 | Swansea Bay University Health BoardOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07148128 | Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. | recruiting | Phase 1 / Phase 2 | 110 | Auricula Biosciences Inc.INDUSTRY | 3 | Jan 29, 2026 | clinicaltrials |
| NCT06923761 | EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)(EMITT-1) | recruiting | Phase 1 / Phase 2 | 300 | Grey Wolf TherapeuticsOTHER | 4 | Jan 28, 2026 | clinicaltrials |
| NCT07151040 | Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors(ODIN) | recruiting | Phase 1 / Phase 2 | 43 | One-carbon Therapeutics ABINDUSTRY | 3 | Jan 28, 2026 | clinicaltrials |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | recruiting | Phase 3 | 892 | GlaxoSmithKlineINDUSTRY | 28 | Jan 23, 2026 | clinicaltrials |
| NCT06818136 | Bladder EpiCheck European Haematuria Study | recruiting | — | 800 | Nucleix Ltd.INDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours(5G-RUBY) | recruiting | Phase 1 / Phase 2 | 182 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06689293 | Faecal Immunochemical Tests (FIT) for Surveillance After Colorectal Cancer (CRC) Study(FITS) | recruiting | — | 1,000 | Nottingham University Hospitals NHS TrustOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06712459 | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma | recruiting | — | 100 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 7 | Jan 16, 2026 | clinicaltrials |
| NCT07341464 | Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends(Blends) | recruiting | N/A | 50 | Société des Produits Nestlé (SPN)INDUSTRY | 1 | Jan 14, 2026 | clinicaltrials |
| NCT03829254 | A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma | recruiting | Phase 1 / Phase 2 | 135 | NuCana plcOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT06117059 | The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance(PRECISION) | recruiting | N/A | 100 | NHS LothianOTHER_GOV | 1 | Jan 12, 2026 | clinicaltrials |
| NCT06163430 | A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)(CARDINAL) | recruiting | Phase 1 / Phase 2 | 180 | Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 9 | Jan 12, 2026 | clinicaltrials |
| NCT07334301 | A Multi-Arm, Platform Trial For Relapsed Neuroblastoma(BEACON2) | recruiting | Phase 1 / Phase 2 | 160 | University of BirminghamOTHER | 5 | Jan 12, 2026 | clinicaltrials |
| NCT07335120 | A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma(ALMANAC) | recruiting | — | 800 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05270096 | International Leukemia Target Board(iLTB) | recruiting | — | 600 | Princess Maxima Center for Pediatric OncologyOTHER | 7 | Jan 9, 2026 | clinicaltrials |
| NCT06557343 | Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy(SPITFIRE) | recruiting | — | 5 | NHS LothianOTHER_GOV | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06265727 | A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors | recruiting | Phase 1 / Phase 2 | 348 | Corbus Pharmaceuticals Inc.INDUSTRY | 7 | Jan 8, 2026 | clinicaltrials |
| NCT06584123 | Molecular Pituitary Imaging Using 18F-FET PET(FET-pit-PET) | recruiting | N/A | 20 | University of CambridgeOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT02986516 | Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease(SACRO) | recruiting | N/A | 100 | Italian Sarcoma GroupNETWORK | 10 | Jan 2, 2026 | clinicaltrials |
| NCT06717295 | The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling(CCANED-CIPHER) | recruiting | — | 6,000 | Javier ToledoINDUSTRY | 3 | Jan 2, 2026 | clinicaltrials |
| NCT06531499 | A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study(RADIODOSE) | recruiting | Phase 1 | 106 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 31, 2025 | clinicaltrials |
| NCT07046546 | Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules(TArGET) | recruiting | N/A | 10 | Royal Berkshire NHS Foundation TrustOTHER_GOV | 1 | Dec 24, 2025 | clinicaltrials |
| NCT07300683 | Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma(FRACTALL) | recruiting | Phase 1 | 24 | University College, LondonOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06468124 | Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases(PDO) | recruiting | — | 20 | King's College LondonOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06659146 | Thermotherapy in Addition to SOC Palliative Radiotherapy(ThermoRad wIRA) | recruiting | N/A | 60 | King's College LondonOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT04550104 | A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC(CONCORDE) | recruiting | Phase 1 | 200 | University of LeedsOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT06511648 | Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations(SOGUG-NEOWIN) | recruiting | Phase 2 | 90 | Spanish Oncology Genito-Urinary GroupOTHER | 4 | Dec 19, 2025 | clinicaltrials |
| NCT07171190 | Targeted Abdominal CT in Conjunction With Lung Cancer Screening(TACTICAL1) | recruiting | N/A | 6,272 | University of CambridgeOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT05259605 | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | recruiting | — | 1,650 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Dec 17, 2025 | clinicaltrials |
| NCT04763317 | Precision Medicine in the Prostate Cancer Care Pathway(PMPRC) | recruiting | — | 3,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.(GENPET) | recruiting | — | 50 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT07278622 | Virtual Group Prehabilitation Education (Surgery School) Feasibility Trial(GoPREPARE) | recruiting | N/A | 24 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT05642819 | REVOLUTION Surgery (REVOLUTION Surgery) | recruiting | — | 200 | University of EdinburghOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT05786716 | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Dec 2, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials